SEC Form 4 · accession 0001209191-18-037645
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Michelle Berrey
Officer — President and CEO · Director
Period of report
Jun 12, 2018
Accepted (ET)
Jun 14, 2018 · 11:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 12, 2018 | P | 10,000 | $4.5015 | A | 99,685 | I | By the M. Michelle Berrey Revocable Trust u/a 12/30/08 |
| Common Stock | holding | — | — | — | 325,256 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The range of purchase prices paid is $4.445 to $4.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.